Aethlon Medical
AEMD
3 hedge funds and large institutions have $2.12M invested in Aethlon Medical in 2016 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0.06% less ownership
Funds ownership: 5.21% → 5.15% (-0.06%)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $192K
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
-$111K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$77K |
| 3 |
US Bancorp
Minneapolis,
Minnesota
|
-$4K |
AEMD Hedge Fund Activity: Q1 2016 in Review
3 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2016, worth a combined $2.12M — down 22% from $2.7M a quarter earlier.
Fund positioning in AEMD was balanced in Q1 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was Bank of New York Mellon, cutting an estimated $111K.
- 3 institutional investors held Aethlon Medical (AEMD) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $2.12M of Aethlon Medical stock for Q1 2016, down 22% quarter-over-quarter.
- 0 funds opened new Aethlon Medical positions in Q1 2016 and 0 closed out.
- The largest Aethlon Medical seller in Q1 2016 was Bank of New York Mellon, an estimated $111K sold.
Based on aggregated 13F filings for Q1 2016.